<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37201420</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-7206</ISSN><JournalIssue CitedMedium="Internet"><Volume>139</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Molecular genetics and metabolism</Title><ISOAbbreviation>Mol Genet Metab</ISOAbbreviation></Journal><ArticleTitle>COVID-19 in inherited metabolic disorders: Clinical features and risk factors for disease severity.</ArticleTitle><Pagination><StartPage>107607</StartPage><MedlinePgn>107607</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ymgme.2023.107607</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1096-7192(23)00237-8</ELocationID><Abstract><AbstractText Label="BACKGROUND">Old age, obesity, and certain chronic conditions are among the risk factors for severe COVID-19. More information is needed on whether inherited metabolic disorders (IMD) confer risk of more severe COVID-19. We aimed to establish COVID-19 severity and associated risk factors in patients with IMD currently followed at a single metabolic center.</AbstractText><AbstractText Label="METHODS">Among all IMD patients followed at a single metabolic referral center who had at least one clinic visit since 2018, those with accessible medical records were reviewed for SARS-CoV-2 tests. COVID-19 severity was classified according to the WHO recommendations, and IMD as per the international classification of IMD.</AbstractText><AbstractText Label="RESULTS">Among the 1841 patients with IMD, 248 (13.5%) had tested positive for COVID-19, 223 of whom gave consent for inclusion in the study (131 children and 92 adults). Phenylalanine hydroxylase (48.4%) and biotinidase (12.1%) deficiencies were the most common diagnoses, followed by mucopolysaccharidoses (7.2%). 38.1% had comorbidities, such as neurologic disabilities (22%) or obesity (9.4%). The majority of COVID-19 episodes were asymptomatic (16.1%) or mild (77.6%), but 6 patients (2.7%) each had moderate and severe COVID-19, and two (0.9%) had critical COVID-19, both of whom died. 3 patients had an acute metabolic decompensation during the infection. Two children developed multisystem inflammatory syndrome (MIS-C). Long COVID symptoms were present in 25.2%. Presence of comorbidities was significantly associated with more severe COVID-19 in adults with IMD (p&#xa0;&lt;&#xa0;0.01), but not in children (p&#xa0;=&#xa0;0.45). Compared to other categories of IMD, complex molecule degradation disorders were significantly associated with more severe COVID-19 in children (p&#xa0;&lt;&#xa0;0.01); such a significant IMD category distinction was not found in adults.</AbstractText><AbstractText Label="DISCUSSION">This is the largest study on COVID-19 in IMD patients relying on real-word data and objective definitions, and not on merely expert opinions or physician surveys. COVID-19 severity and long COVID incidence in IMD are probably similar to the general population, and the risk of acute metabolic decompensation is not likely to be greater than that in other acute infections. Disease category (complex molecule degradation) in children, and comorbidities in adults may be associated with COVID-19 severity in IMD. Additionally, the first documented accounts of COVID-19 in 27 different IMD are recorded. The high occurrence of MIS-C may be coincidental, but warrants further study.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kahraman</LastName><ForeName>Ayca Burcu</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Hacettepe University Faculty of Medicine, Department of Pediatrics, Division of Pediatric Metabolism, Turkey. Electronic address: aycaburcuoksuz@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Y&#x131;ld&#x131;z</LastName><ForeName>Y&#x131;lmaz</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Hacettepe University Faculty of Medicine, Department of Pediatrics, Division of Pediatric Metabolism, Turkey. Electronic address: yilmaz.yildiz@hacettepe.edu.tr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xc7;&#x131;k&#x131;</LastName><ForeName>K&#x131;smet</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Hacettepe University Faculty of Medicine, Department of Pediatrics, Division of Pediatric Metabolism, Turkey. Electronic address: kismet.ciki@hacettepe.edu.tr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erdal</LastName><ForeName>Izzet</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Hacettepe University Faculty of Medicine, Department of Pediatrics, Division of Pediatric Metabolism, Turkey. Electronic address: izzet.erdal@hacettepe.edu.tr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akar</LastName><ForeName>Halil Tuna</ForeName><Initials>HT</Initials><AffiliationInfo><Affiliation>Hacettepe University Faculty of Medicine, Department of Pediatrics, Division of Pediatric Metabolism, Turkey. Electronic address: halil.tuna.akar@hacettepe.edu.tr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dursun</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hacettepe University Faculty of Medicine, Department of Pediatrics, Division of Pediatric Metabolism, Turkey. Electronic address: adursun@hacettepe.edu.tr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tokatl&#x131;</LastName><ForeName>Ay&#x15f;eg&#xfc;l</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hacettepe University Faculty of Medicine, Department of Pediatrics, Division of Pediatric Metabolism, Turkey. Electronic address: atokatli@hacettepe.edu.tr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sivri</LastName><ForeName>Serap</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hacettepe University Faculty of Medicine, Department of Pediatrics, Division of Pediatric Metabolism, Turkey. Electronic address: ssivri@hacettepe.edu.tr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Genet Metab</MedlineTA><NlmUniqueID>9805456</NlmUniqueID><ISSNLinking>1096-7192</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C000705967">pediatric multisystem inflammatory disease, COVID-19 related</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062072" MajorTopicYN="N">Patient Acuity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008659" MajorTopicYN="Y">Metabolic Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Comorbidity</Keyword><Keyword MajorTopicYN="N">Coronavirus disease 2019 (COVID-19)</Keyword><Keyword MajorTopicYN="N">Disorders of complex molecule degradation</Keyword><Keyword MajorTopicYN="N">Inherited metabolic diseases</Keyword><Keyword MajorTopicYN="N">Pneumonia</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>13</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>1</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>18</Day><Hour>18</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37201420</ArticleId><ArticleId IdType="pmc">PMC10171899</ArticleId><ArticleId IdType="doi">10.1016/j.ymgme.2023.107607</ArticleId><ArticleId IdType="pii">S1096-7192(23)00237-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dessie Z.G., Zewotir T. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect. Dis. 2021;21:855.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8380115</ArticleId><ArticleId IdType="pubmed">34418980</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira C.R., Rahman S., Keller M., Zschocke J., Group I.A., Abdenur J., Ali H., Artuch R., Ballabio A., Barshop B. An international classification of inherited metabolic disorders (ICIMD) J. Inherit. Metab. Dis. 2021;44:164&#x2013;177.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9021760</ArticleId><ArticleId IdType="pubmed">33340416</ArticleId></ArticleIdList></Reference><Reference><Citation>Mercolini F., Don&#xe0; D., Girtler Y., Mussner K.A., Biban P., Bordugo A., Molinaro G. First paediatric COVID-19 associated death in Italy. J. Paediatr. Child Health. 2021 May;57(5):736&#x2013;737.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361632</ArticleId><ArticleId IdType="pubmed">32592522</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahraman A.B., Yildiz Y., Ciki K., Akar H.T., Erdal I., Dursun A., Tokatli A., Sivri H.S. Invisible burden of COVID-19: enzyme replacement therapy disruptions. J. Pediatr. Endocrinol. Metab. 2021;34:539&#x2013;545.</Citation><ArticleIdList><ArticleId IdType="pubmed">33818036</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko&#xe7; Yeked&#xfc;z M., Do&#x11f;ulu N., S&#xfc;r&#xfc;c&#xfc; Kara &#x130;., &#xd6;nc&#xfc;l &#xdc;., Bakirarar B., Kullu P., Ar Y., K&#xf6;se E., Emino&#x11f;lu F.T. 2022. Pros and Cons of Telemedicine for Inherited Metabolic Disorders in a Developing Country during the COVID-19 Pandemic Telemedicine and e-Health.</Citation><ArticleIdList><ArticleId IdType="pubmed">35363077</ArticleId></ArticleIdList></Reference><Reference><Citation>Paneghetti L., Bellettato C.M., Sechi A., Stepien K.M., Scarpa M. One year of COVID-19: infection rates and symptoms in patients with inherited metabolic diseases followed by MetabERN. Orphan. J. Rare Dis. 2022;17:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8894822</ArticleId><ArticleId IdType="pubmed">35246188</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasnat F., Noman F., Moben A., Sarker A., Morshed J., Mutanabbi M. Difference in clinical patterns between COVID-19. Affected Childr. Adults Mymensingh Med. J. 2021;30:1093&#x2013;1099.</Citation><ArticleIdList><ArticleId IdType="pubmed">34605482</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;tze U., Gleich F., Bari&#x107; I., Baumgartner M., Burlina A., Chapman K.A., Chien Y.H., Cort&#xe8;s-Saladelafont E., De Laet C., Dobbelaere D. Impact of the SARS-CoV-2 pandemic on the health of individuals with intoxication-type metabolic diseases&#x2014;data from the E-IMD consortium. J. Inherit. Metab. Dis. 2023;46:220&#x2013;231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9874390</ArticleId><ArticleId IdType="pubmed">36266255</ArticleId></ArticleIdList></Reference><Reference><Citation>Living guidance for clinical management of COVID-19. 2021.</Citation></Reference><Reference><Citation>International Guidelines for Certification and Classification (Coding) of COVID-19 as Cause of Death. 2020.</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention . 2020. Emergency Pre- Paredness and Response: Health Alert Network.</Citation></Reference><Reference><Citation>Cui X., Zhao Z., Zhang T., Guo W., Guo W., Zheng J., Zhang J., Dong C., Na R., Zheng L., Li W., Liu Z., Ma J., Wang J., He S., Xu Y., Si P., Shen Y., Cai C. A systematic review and meta-analysis of children with coronavirus disease 2019 (COVID-19) J. Med. Virol. 2021;93:1057&#x2013;1069.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7436402</ArticleId><ArticleId IdType="pubmed">32761898</ArticleId></ArticleIdList></Reference><Reference><Citation>Assa A., Benninga M.A., Borrelli O., Broekaert I., de Carpi J.M., Saccomani M.D., Dolinsek J., Mas E., Miele E., Thomson M., Tzivinikos C., E. Gastrointestinal Committee of Gastrointestinal perspective of coronavirus disease 2019 in children-an updated review. J. Pediatr. Gastroenterol. Nutr. 2021;73:299&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8373385</ArticleId><ArticleId IdType="pubmed">34117195</ArticleId></ArticleIdList></Reference><Reference><Citation>Platt F.M., d&#x2019;Azzo A., Davidson B.L., Neufeld E.F., Tifft C.J. Lysosomal storage diseases. Nat. Rev. Dis. Prim. 2018;4:1&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">30275469</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh A., Morris A.A. Acute presentations of inherited metabolic disorders: investigation and initial management. Paediatr. Child Health. 2019;29:99&#x2013;104.</Citation></Reference><Reference><Citation>Zwickler T., Riderer A., Haege G., Hoffmann G.F., Kolker S., Burgard P. Usefulness of biochemical parameters in decision-making on the start of emergency treatment in patients with propionic acidemia. J. Inherit. Metab. Dis. 2014;37:31&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">23797949</ArticleId></ArticleIdList></Reference><Reference><Citation>Zwickler T., Haege G., Riderer A., Horster F., Hoffmann G.F., Burgard P., Kolker S. Metabolic decompensation in methylmalonic aciduria: which biochemical parameters are discriminative? J. Inherit. Metab. Dis. 2012;35:797&#x2013;806.</Citation><ArticleIdList><ArticleId IdType="pubmed">22249333</ArticleId></ArticleIdList></Reference><Reference><Citation>Forny P., H&#xf6;rster F., Ballhausen D., Chakrapani A., Chapman K.A., Dionisi-Vici C., Dixon M., Gr&#xfc;nert S.C., Grunewald S., Haliloglu G. Guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia: first revision. J. Inherit. Metab. Dis. 2021;44:566&#x2013;592.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8252715</ArticleId><ArticleId IdType="pubmed">33595124</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubarioglu T., Hopurcuoglu D., Ahmadzada S., Uzunyayla-Inci G., Cansever M.S., Kiykim E., Aktuglu-Zeybek C. Inborn errors of metabolism and COVID-19: Evaluation of the metabolic outcome, Pediatr Int. 2022 Jan;64(1):e14938.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8447071</ArticleId><ArticleId IdType="pubmed">34329521</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur S., Campbell S.L., Stockton D.W. Management of COVID-19 infection in organic acidemias. Am. J. Med. Genet. A. 2021;185:1854&#x2013;1857.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8250661</ArticleId><ArticleId IdType="pubmed">33686767</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumgartner M.R., H&#xf6;rster F., Dionisi-Vici C., Haliloglu G., Karall D., Chapman K.A., Huemer M., Hochuli M., Assoun M., Ballhausen D. Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia. Orphan. J. Rare Dis. 2014;9:1&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4180313</ArticleId><ArticleId IdType="pubmed">25205257</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann P., Pittet L.F., Curtis N. How common is long COVID in children and adolescents? Pediatr. Infect. Dis. J. 2021;40</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8575095</ArticleId><ArticleId IdType="pubmed">34870392</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz I.V.D., Randon D.N., Monsores N., Moura de Souza C.F., Horovitz D.D.G., Wilke M.V.M.B., Brunoni D. SARS-CoV-2 pandemic in the Brazilian community of rare diseases: a patient reported survey. Am. J. Med. Genet. C: Semin. Med. Genet. 2021:301&#x2013;311. Wiley Online Library.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8014801</ArticleId><ArticleId IdType="pubmed">33474836</ArticleId></ArticleIdList></Reference><Reference><Citation>Lampe C., Dionisi-Vici C., Bellettato C., Paneghetti L., Van Lingen C., Bond S., Brown C., Finglas A., Francisco R., Sestini S. The impact of COVID-19 on rare metabolic patients and healthcare providers: results from two MetabERN surveys. Orphan. J. Rare Dis. 2020;15:1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7711270</ArticleId><ArticleId IdType="pubmed">33272301</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi J.H., Choi S.-H., Yun K.W. Risk factors for severe COVID-19 in children: a systematic review and meta-analysis. Journal of Korean Medical Science. 2022;37</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8822112</ArticleId><ArticleId IdType="pubmed">35132841</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen A., Huang J.-x., Liao Y., Liu Z., Chen D., Yang C., Yang R.-m., Wei X. Vol. 2. 2020. Differences in Clinical and Imaging Presentation of Pediatric Patients with COVID-19 in Comparison with Adults Radiology: Cardiothoracic Imaging.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7233434</ArticleId><ArticleId IdType="pubmed">33778567</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong Y., Mo X., Hu Y., Qi X., Jiang F., Jiang Z., Tong S. Vol. 145. 2020. Epidemiology of COVID-19 among Children in China Pediatrics.</Citation><ArticleIdList><ArticleId IdType="pubmed">32179660</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhochak N., Singhal T., Kabra S., Lodha R. Pathophysiology of COVID-19: why children fare better than adults? Indian J. Pediatr. 2020;87:537&#x2013;546.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7221011</ArticleId><ArticleId IdType="pubmed">32410003</ArticleId></ArticleIdList></Reference><Reference><Citation>Yayla B.C.C., Aykac K., Ozsurekci Y., Ceyhan M. Characteristics and Management of Children with COVID-19 in a tertiary Care Hospital in Turkey. Clin. Pediatr. (Phila) 2021;60:170&#x2013;177.</Citation><ArticleIdList><ArticleId IdType="pubmed">33034209</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B., Bluemke D.A., L&#xfc;scher T.F., Neubauer S. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur. Heart J. 2022;43:1157&#x2013;1172.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="pubmed">35176758</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludvigsson J.F. Case report and systematic review suggest that children may experience similar long-term effects to adults after clinical COVID-19. Acta Paediatr. 2021;110:914&#x2013;921.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7753397</ArticleId><ArticleId IdType="pubmed">33205450</ArticleId></ArticleIdList></Reference><Reference><Citation>Payne A.B., Gilani Z., Godfred-Cato S., Belay E.D., Feldstein L.R., Patel M.M., Randolph A.G., Newhams M., Thomas D., Magleby R., Hsu K., Burns M., Dufort E., Maxted A., Pietrowski M., Longenberger A., Bidol S., Henderson J., Sosa L., Edmundson A., Tobin-D'Angelo M., Edison L., Heidemann S., Singh A.R., Giuliano J.S., Jr., Kleinman L.C., Tarquinio K.M., Walsh R.F., Fitzgerald J.C., Clouser K.N., Gertz S.J., Carroll R.W., Carroll C.L., Hoots B.E., Reed C., Dahlgren F.S., Oster M.E., Pierce T.J., Curns A.T., Langley G.E., Campbell A.P., M.-C.I.A. Group, Balachandran N., Murray T.S., Burkholder C., Brancard T., Lifshitz J., Leach D., Charpie I., Tice C., Coffin S.E., Perella D., Jones K., Marohn K.L., Yager P.H., Fernandes N.D., Flori H.R., Koncicki M.L., Walker K.S., Di Pentima M.C., Li S., Horwitz S.M., Gaur S., Coffey D.C., Harwayne-Gidansky I., Hymes S.R., Thomas N.J., Ackerman K.G., Cholette J.M. Incidence of multisystem inflammatory syndrome in children among US persons infected with SARS-CoV-2. JAMA Netw. Open. 2021;4 e2116420.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8193431</ArticleId><ArticleId IdType="pubmed">34110391</ArticleId></ArticleIdList></Reference><Reference><Citation>Holm M, Hartling UB, Schmidt LS, Glenth&#xf8;j JP, Kruse A, Rytter MH, Lindhard MS, Lawaetz MC, Zaharov T, Petersen JJ, Andersen RM, Lemvik G, Marcinski P, Thaarup J, Jensen LH, Borch L, Nielsen AB, Vissing NH, Schmiegelow K, Nygaard U. Multisystem inflammatory syndrome in children occurred in one of four thousand children with severe acute respiratory syndrome coronavirus 2. Acta Paediatr. 2021 Sep;110(9):2581&#x2013;2583. doi: 10.1111/apa.15985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15985</ArticleId><ArticleId IdType="pmc">PMC8444758</ArticleId><ArticleId IdType="pubmed">34129731</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>